174 related articles for article (PubMed ID: 25106841)
41. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid.
Erbayat Altay E; Serdaroğlu A; Tümer L; Gücüyener K; Hasanoğlu A
J Pediatr Endocrinol Metab; 2000; 13(7):933-9. PubMed ID: 10968482
[TBL] [Abstract][Full Text] [Related]
42. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
Finkelstein JS; Hayes A; Hunzelman JL; Wyland JJ; Lee H; Neer RM
N Engl J Med; 2003 Sep; 349(13):1216-26. PubMed ID: 14500805
[TBL] [Abstract][Full Text] [Related]
43. Bone Mineral Density, 25-OH Vitamin D and Inflammation in Patients with Psoriasis.
Solak B; Dikicier BS; Celik HD; Erdem T
Photodermatol Photoimmunol Photomed; 2016 May; 32(3):153-60. PubMed ID: 26869073
[TBL] [Abstract][Full Text] [Related]
44. Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs.
Kulak CA; Borba VZ; Bilezikian JP; Silvado CE; Paola Ld; Boguszewski CL
Arq Neuropsiquiatr; 2004 Dec; 62(4):940-8. PubMed ID: 15608949
[TBL] [Abstract][Full Text] [Related]
45. Bone mineral density and its correlation with vitamin D status in healthy school-going children of Western India.
Sharawat IK; Dawman L
Arch Osteoporos; 2019 Feb; 14(1):13. PubMed ID: 30712114
[TBL] [Abstract][Full Text] [Related]
46. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
Ganesh R; Suresh N; Janakiraman L; Ravikumar K
Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of vitamin D status bone mineral density and dental health in children with cholestasis.
Samra NM; Emad El Abrak S; El Dash HH; El Said El Raziky M; El Sheikh MA
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):368-377. PubMed ID: 29551613
[TBL] [Abstract][Full Text] [Related]
48. Predictors of bone density in ambulatory patients on antiepileptic drugs.
El-Hajj Fuleihan G; Dib L; Yamout B; Sawaya R; Mikati MA
Bone; 2008 Jul; 43(1):149-155. PubMed ID: 18467202
[TBL] [Abstract][Full Text] [Related]
49. Comparison of vitamin D levels with bone density, calcium, phosphate and alkaline phosphatase - an insight from major cities of Pakistan.
Nadeem Saqib MA; Rafique I; Hayder I; Irshad R; Bashir S; Ullah R; Awan NJ
J Pak Med Assoc; 2018 Apr; 68(4):543-547. PubMed ID: 29808042
[TBL] [Abstract][Full Text] [Related]
50. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
Ghannam NN; Hammami MM; Bakheet SM; Khan BA
Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
[TBL] [Abstract][Full Text] [Related]
51. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
52. Low bone mineral density and vitamin d deficiency correlated with genetics and other bone markers in female Turkish immigrants in Germany.
Tastan Y; Kann PH; Tinneberg HR; Hadji P; Müller-Ladner U; Lange U
Clin Rheumatol; 2016 Nov; 35(11):2789-2795. PubMed ID: 27034172
[TBL] [Abstract][Full Text] [Related]
53. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
Olmos JM; Hernández JL; García-Velasco P; Martínez J; Llorca J; González-Macías J
Osteoporos Int; 2016 Jan; 27(1):105-13. PubMed ID: 26134682
[TBL] [Abstract][Full Text] [Related]
54. Low-calcium dialysate as a risk factor for decline in bone mineral density in peritoneal dialysis patients.
Kang SH; Cho KH; Park JW; Yoon KW; Do JY
Scand J Urol Nephrol; 2012 Dec; 46(6):454-60. PubMed ID: 22938029
[TBL] [Abstract][Full Text] [Related]
55. Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major.
Tantawy AA; El Kholy M; Moustafa T; Elsedfy HH
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():132-5. PubMed ID: 19337166
[TBL] [Abstract][Full Text] [Related]
56. The effect of levetiracetam and oxcarbazepine monotherapy on thyroid hormones and bone metabolism in children with epilepsy: A prospective study.
Shi KL; Guo JX; Zhao HM; Hong H; Yang CZ; Wu YH; Du LJ
Epilepsy Behav; 2020 Dec; 113():107555. PubMed ID: 33242769
[TBL] [Abstract][Full Text] [Related]
57. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
[TBL] [Abstract][Full Text] [Related]
58. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
Guo CY; Ronen GM; Atkinson SA
Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
[TBL] [Abstract][Full Text] [Related]
59. Adverse effects of antiepileptic drugs on bone mineral density in children.
Gissel T; Poulsen CS; Vestergaard P
Expert Opin Drug Saf; 2007 May; 6(3):267-78. PubMed ID: 17480176
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug.
Phabphal K; Geater A; Leelawattana R; Sathirapunya P; Sattawatcharawanich S; Limapichat K
Bone; 2009 Aug; 45(2):232-7. PubMed ID: 19394456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
